AU2001253852A1 - Preprocalcitonin as tumor rejection antigen precursor and uses thereof - Google Patents

Preprocalcitonin as tumor rejection antigen precursor and uses thereof

Info

Publication number
AU2001253852A1
AU2001253852A1 AU2001253852A AU5385201A AU2001253852A1 AU 2001253852 A1 AU2001253852 A1 AU 2001253852A1 AU 2001253852 A AU2001253852 A AU 2001253852A AU 5385201 A AU5385201 A AU 5385201A AU 2001253852 A1 AU2001253852 A1 AU 2001253852A1
Authority
AU
Australia
Prior art keywords
preprocalcitonin
tumor rejection
rejection antigen
antigen precursor
precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253852A
Other languages
English (en)
Inventor
Jean Francois Baurain
Thierry Boon-Falleur
Salem Chouaib
Pierre G Coulie
Hamid Echchakir
Fathia Mami-Chouaib
Isabelle Vergnon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Institut Gustave Roussy (IGR)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Ludwig Institute for Cancer Research Ltd
Institut Gustave Roussy (IGR)
Institut National de la Sante et de la Recherche Medicale INSERM
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Institut Gustave Roussy (IGR), Institut National de la Sante et de la Recherche Medicale INSERM, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Publication of AU2001253852A1 publication Critical patent/AU2001253852A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001253852A 2000-03-31 2001-03-14 Preprocalcitonin as tumor rejection antigen precursor and uses thereof Abandoned AU2001253852A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53956700A 2000-03-31 2000-03-31
US09/539,567 2000-03-31
PCT/US2001/040288 WO2001075179A2 (fr) 2000-03-31 2001-03-14 Preprocalcitonine utilisee comme precurseur d'antigene de rejet tumoral et ses utilisations

Publications (1)

Publication Number Publication Date
AU2001253852A1 true AU2001253852A1 (en) 2001-10-15

Family

ID=24151778

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253852A Abandoned AU2001253852A1 (en) 2000-03-31 2001-03-14 Preprocalcitonin as tumor rejection antigen precursor and uses thereof

Country Status (3)

Country Link
EP (1) EP1301624A2 (fr)
AU (1) AU2001253852A1 (fr)
WO (1) WO2001075179A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008504850A (ja) * 2004-06-16 2008-02-21 アフィナジー， インコーポレイテッド 整形外科インプラントの表面に対する標的分析物の特異的接着を促進するためのｉｆｂｍ
EP2006384A1 (fr) * 2007-06-22 2008-12-24 Institut Gustave Roussy Epitopes d'antigènes dérivés de la préprocalcitonin
US20130046085A1 (en) * 2011-06-22 2013-02-21 Universidad De Sevilla Antibodies against n-procalcitonin
EP3115058A1 (fr) * 2015-07-09 2017-01-11 Institut Gustave Roussy Peptides immunogenes de preprocalcitonine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU662906B2 (en) * 1991-06-26 1995-09-21 F. Hoffmann-La Roche Ag Methods for detection of carcinoma metastases by nucleic acid amplification
DE19600875C1 (de) * 1996-01-12 1997-06-26 Brahms Diagnostica Gmbh Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse
US5993811A (en) * 1997-02-03 1999-11-30 Biology Associates, Llc Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis

Also Published As

Publication number Publication date
WO2001075179A2 (fr) 2001-10-11
WO2001075179A3 (fr) 2003-02-06
EP1301624A2 (fr) 2003-04-16

Similar Documents

Publication Publication Date Title
AU2002244968A1 (en) Anti-osteopontin antibody and use thereof
AU2002251913A1 (en) Hybrid antibodies and uses thereof
AU2001229682A1 (en) Small cell lung cancer associated antigens and uses therefor
AU2002367931A1 (en) Alumina-yttria-zirconium oxide/hafnium oxide materials, and methods of making and using the same
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
GB9927332D0 (en) Novel antibody and uses thereof
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2001290860A1 (en) Spas-1 cancer antigen
AU2002211717A1 (en) Stresscopins and their uses
AU2002213331A1 (en) Cobalt-containing catalyst precursor and preparation thereof
AU2002349543A1 (en) Tumor antigens
AU2001296709A1 (en) Gemstone
AU2002243314A1 (en) Immunogenic cancer peptides and uses thereof
GB0114517D0 (en) Trx1 antibody and uses therefor
AU2002251821A1 (en) Nicotine immunogens and antibodies and uses thereof
AU2001253852A1 (en) Preprocalcitonin as tumor rejection antigen precursor and uses thereof
AU2002312373A1 (en) Structural and cytoskeleton-associated proteins
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU2001261534A1 (en) The meca-79 antigen and related methods
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU5632500A (en) Cancer associated antigens and uses therefor
AU2002251543A1 (en) Novel atisane compound and use thereof
AU2001268903A1 (en) Hexaglucal compound and the use and the methods of preparing them